Lifecore Biomedical, Inc.

NasdaqGS:LFCR 주식 보고서

시가총액: US$145.7m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Lifecore Biomedical 관리

관리 기준 확인 2/4

Lifecore Biomedical's CEO는 Paul Josephs, May2024 에 임명되었습니다 의 임기는 1년 미만입니다. 는 $ 2.52M 가치에 해당하는 회사 주식의 1.69% 직접 소유합니다. 2.52M. 경영진과 이사회의 평균 재임 기간은 각각 2.1 년과 3.7 년입니다.

주요 정보

Paul Josephs

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기less than a year
CEO 소유권1.7%
경영진 평균 재임 기간2.2yrs
이사회 평균 재임 기간3.8yrs

최근 관리 업데이트

Recent updates

Lifecore Biomedical: No Sale Soon Amidst Leverage And Uncertainty

Jun 24

White Falcon Capital - Lifecore Biomedical: Potential For Rapid Growth In Earnings And FCF Surge

Apr 20

Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?

Jun 30
Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?

Landec Non-GAAP EPS of -$0.32, revenue of $43.35M

Oct 06

Landec receives Nasdaq's notification on delayed annual report filing

Sep 09

Laughing Water Capital - Landec Corp. : A High Quality CDMO

Jul 27

Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt

Jun 24
Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt

Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report

Apr 08
Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report

Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet

Mar 21
Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet

Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital

Nov 30
Here's What's Concerning About Landec's (NASDAQ:LNDC) Returns On Capital

Optimistic About Landec's Strategic Initiatives And Sodium Hyaluronate Products

Nov 05

Landec Still In Play As An Activist Investment

Aug 20

Is Landec (NASDAQ:LNDC) Using Too Much Debt?

May 25
Is Landec (NASDAQ:LNDC) Using Too Much Debt?

Is Landec (NASDAQ:LNDC) Using Too Much Debt?

Feb 24
Is Landec (NASDAQ:LNDC) Using Too Much Debt?

CEO

Paul Josephs

less than a year

테뉴어

Mr. Paul Josephs is President, CEO & Director of Lifecore Biomedical, Inc. from May 20, 2024. Mr. Josephs is President & CEO of Woodstock Sterile Solutions, Inc. Mr. Josephs serves as Senior Vice President...


리더십 팀

이름위치테뉴어보상소유권
John Morberg
Executive VP & CFO3.5yrsUS$927.10k0.66%
$ 968.0k
James Hall
Advisorless than a yearUS$1.76m1.45%
$ 2.1m
Albert Bolles
President of Curation Foods1.9yrsUS$1.34m1.42%
$ 2.1m
Paul Josephs
Presidentless than a year데이터 없음1.69%
$ 2.5m
Kipling Thacker
VP & Chief Scientist1.3yrs데이터 없음데이터 없음
Aaron Perlitsh
Director of Internal Audit & Chief Compliance Officerno data데이터 없음데이터 없음
Darren Hieber
Senior Vice President of Corporate Development & Partnerships2.5yrs데이터 없음데이터 없음
Jackie Klecker
Executive VP & GM2.5yrs데이터 없음데이터 없음
Matt Augustson
Senior Vice President of Information Technology2.5yrs데이터 없음데이터 없음
Parker Javid
Vice Presidentno dataUS$460.69k데이터 없음

2.2yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 관리: LFCR 의 관리팀은 경험 ( 2.1 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Paul Josephs
Presidentless than a year데이터 없음1.69%
$ 2.5m
Nelson Obus
Independent Director5.8yrsUS$180.00k0.062%
$ 90.7k
Katrina Houde
Independent Director4.9yrsUS$185.00k0.14%
$ 199.0k
Jeffrey Edwards
Independent Director3.8yrsUS$183.33k0.10%
$ 150.2k
Joshua Schechter
Independent Director3.8yrsUS$170.00k0.14%
$ 197.9k
Christopher Kiper
Director1.5yrs데이터 없음데이터 없음
Raymond Diradoorian
Independent Director2.5yrsUS$50.00k0.071%
$ 103.9k
Craig Barbarosh
Independent Chairman4.8yrsUS$255.00k0.19%
$ 277.0k
Nathaniel Calloway
Director1.5yrs데이터 없음0%
$ 0

3.8yrs

평균 재임 기간

59.5yo

평균 연령

경험이 풍부한 이사회: LFCR 의 이사회경험(평균 재직 기간 3.7 년)으로 간주됩니다.